The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia.

scientific article published on 19 April 2018

The effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/LIO2.157
P932PMC publication ID6057218
P698PubMed publication ID30062132

P50authorJamie McDonaldQ88599847
Rhett S ThomsonQ90652322
P2093author name stringLeland Johnson
P Daniel Ward
Kevin J Whitehead
Shaelene Ashby
Kevin F Wilson
Bryan R McRae
Nicole L Molin
P2860cites workHereditary haemorrhagic telangiectasia: a clinical and scientific reviewQ24600839
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchQ29547257
Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaireQ33212390
The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.Q33213303
Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of ViewQ33662306
The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasiaQ34483680
Pulmonary arteriovenous malformationsQ35044725
Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasiaQ35886777
Treatment of severe refractory epistaxis in hereditary hemorrhagic telangiectasia using a two-flap nasal closure methodQ36869439
Evidence-based management of epistaxis in hereditary haemorrhagic telangiectasiaQ38367321
Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young's procedure: a 22-year experienceQ39033871
Development of a severity classification system for subjective nasal obstructionQ39386346
Health-related quality of life in hereditary hemorrhagic telangiectasiaQ42619248
Systemic therapy with bevacizumab in patients with hereditary hemorrhagic telangiectasia (HHT).Q44675818
The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia.Q48067519
Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxisQ48293790
Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleedsQ48372227
An epistaxis severity score for hereditary hemorrhagic telangiectasiaQ48906632
A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT)Q64043752
The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasiaQ81582202
Are patients with severe epistaxis caused by hereditary hemorrhagic telangiectasia satisfied with nostril closure surgery?Q84141439
Nasal closure for the treatment of epistaxis secondary to hereditary hemorrhagic telangiectasiaQ89181704
P433issue3
P304page(s)178-181
P577publication date2018-04-19
P1433published inLaryngoscope Investigative OtolaryngologyQ50817247
P1476titleThe effects of nasal closure on quality of life in patients with hereditary hemorrhagic telangiectasia
P478volume3

Search more.